PUNT OF THE WEEK: Biotech firm Oncimmune
PUNT OF THE WEEK: Biotech firm Oncimmune can identify lung cancer years before tumours become visible By Daily Mail City & Finance Reporter Published: 21:51 GMT, 13 March 2020 | Updated: 22:00 GMT, 13 March 2020 Oncimmune is an Aim-listed cancer diagnosis specialist based in Nottingham What is it? An Aim-listed cancer diagnosis specialist based … Read more